Image optimize LCP
  • Add description, images, menus and links to your mega menu

  • A column with no settings can be used as a spacer

  • Link to your collections, sales and even external links

  • Add up to five columns

  • March 21, 2017 2 min read

    TXA was developed for the battlefield in Afghanistan.  Like so many war-inspired innovations, TXA has implications for maternal health and the battle against postpartum hemorrhage.

    Postpartum hemorrhage (PPH) continues to be a leading contributor to maternal mortality worldwide despite various efforts and interventions to prevent and control it. There are methods that have strong evidence supporting its effectiveness but can still benefit from improvements. One of these strategies is the use of a uterine balloon tamponade (UBT), which is recommended by the WHO, International Federation of Gynecology and Obstetrics, and the Royal College of Obstetricians and Gynecologists. The current success rate of the intervention is 60-80%, with the unsuccessful cases requiring further invasive procedures.

    Tranexamic acid (TXA) reduces bleeding by restraining the breakdown of fibrin blood clots and is traditionally injected (Martin et al., 2015). A recent systematic review of 26 randomized controlled trials (Ker et al., 2016) suggests that TXA is an inexpensive, widely available medicine that can reduce blood transfusions in surgery and decrease postpartum blood loss. However, many of these trials contained data of questionable quality and reliability.

    More recently, in cases of severe PPH, doctors have shown that using a combination of UBT with topical administration of TXA can be effective treating excessive hemorrhage. This modified UBT method involves an intrauterine balloon catheter with the balloon portion wrapped in gauze soaked with 20 mL of 5% TXA solution. The balloon is then inserted through the cervix into the uterus and inflated with 210 mL of sterile water until it adequately compresses the inner uterus and the TXA-soaked gauze can adhere tightly to the bleeding spots. In addition, a one-meter long piece of normal gauze is packed in the vagina to keep the balloon in place. A blood transfusion was performed at the same time, in addition to intravenous injections of oxytocin, crystalloid fluid, and antibiotics. Bleeding lessened immediately and stopped completely by the next day and the balloon and gauze were removed 20 hours after insertion. She was discharged in good condition with her newborn 5 days postpartum. Another case treated the same way saw the woman discharged in stable condition 4 days postpartum after receiving 10 hours of the treatment.

    While the two above cases are encouraging, further randomized controlled trials need to be done to confirm the safety and effectiveness of the UBT + topical TXA procedure.

      

    Blog by Vivian Shih.

    Leave a comment

    Comments will be approved before showing up.


    Also in The Maternova Blog

    The novel vital signs alert built into the CRADLE for eclampsia and shock detection
    The novel vital signs alert built into the CRADLE for eclampsia and shock detection

    November 26, 2024 2 min read

    The CRADLE Vital Signs Alert is an innovative semi-automatic device for midwifery and obstetrics.  The device takes blood pressure and heart rate and then calculates shock index, making the whole process semi-automatic. 
    Read More
    NASG or TANN for postpartum hemorrhage CE-marked device
    How does the NASG actually work to stop hemorrhage and reverse shock?

    October 29, 2024 2 min read

    The TANN (in Spanish) or NASG acts as an obstetric first aid device.  There is a large dense foam ball sewn securely into a foam rectangle, all designed to pulled snug around the uterus and tightened with sewn-on velcro.
    Read More
    The bubble CPAP reducing neonatal mortality by 27 percent
    The bubble CPAP reducing neonatal mortality by 27 percent

    September 04, 2024 2 min read

    NIgerian experience with a pilot in 7 hospitals using the bubble CPAP.
    Read More